Download slides from Clinical Care Options examining the optimal use of VEGFR-targeted TKIs in treating patients with solid organ tumors.
In this activity from Clinical Care Options, experts discuss the latest data on treating solid organ tumors with VEGFR inhibitors.
In this slideset from Clinical Care Options, experts provide insights on the use of first-line systemic therapy for advanced HCC.
In this slideset from Clinical Care Options, experts provide insights on the use of immunotherapy for advanced HCC.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.